Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.60 |
| ▸ | CA9 | Q16790 | 3/20 | 0.60 |
| ▸ | CA1 | P00915 | 2/20 | 0.60 |
| ▸ | CYP2A6 | P11509 | 6/20 | 0.55 |
| ▸ | MAOA | P21397 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.47 |
| ▸ | GAA | P10253 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | BCHE | P06276 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Coumarin SCHEMBL7644084 | 0.78 | CA12 (0.67) | CA12CA9CA1MAOAALDH1A1 | |
| SCHEMBL5542888 | 0.77 | CYP2A6 (0.56) | CA12CA9CA1CYP2A6MAOA | |
| SCHEMBL11035090 | 0.75 | CYP2A6 (0.55) | CA12CA9CA1CYP2A6MAOA | |
| SCHEMBL11034294 | 0.75 | CYP2A6 (0.55) | CA12CA9CA1CYP2A6MAOA | |
| SCHEMBL15842364 | 0.75 | CYP2A6 (0.55) | CA12CA9CA1CYP2A6MAOA | |
| SCHEMBL2670683 | 0.75 | NQO1 (0.62) | CA12CA9CA1CYP2A6MAOA | |
| SCHEMBL8252613 | 0.75 | CYP2A6 (0.55) | CA12CA9CA1CYP2A6MAOA | |
| SCHEMBL546445 | 0.75 | CYP2A6 (0.59) | CA12CA9CA1CYP2A6MAOA | |
| 4-Hydroxycoumarins SCHEMBL131312 | 0.75 | CA12 (1.00) | CA12CA9CA1MAOAALDH1A1 | |
| SCHEMBL6783654 | 0.75 | ALDH1A1 (0.53) | CA12CA9CA1CYP2A6MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 399 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4714452-A1 | METHODS FOR TREATING SARS COV-2 INFECTIONS | Gilead Sciences, Inc. (US) | 2026-03-25 | — | — | EP | claimed |
| US-20250064758-A1 | ANTIVIRALS TARGETING PHOSPHATIDIC ACID PHOSPHATASE (PAP) | CENTRE FOR VIROLOGY, VACCINOLOGY AND THERAPEUTICS LIMITED (CN) | 2025-02-27 | — | — | US | claimed |
| CN-117721161-A | Biological-based multifunctional anti-aging auxiliary agent, and preparation method and application thereof | 四川大学 | 2024-03-19 | — | — | CN | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| US-11660307-B2 | Methods for treating SARS CoV-2 infections | GILEAD SCIENCES, INC. (US) | 2023-05-30 | — | — | US | claimed |
| CN-106179495-B | The synthetic method and its catalyst for synthesizing of a kind of loop coil acenaphthylene pyran derivate, the derivative | 马鞍山市泰博化工科技有限公司 | 2018-09-14 | — | — | CN | claimed |
| CN-106179495-A | A kind of volution acenaphthylene pyran derivate, the synthetic method of this derivant and catalyst for synthesizing thereof | 马鞍山市泰博化工科技有限公司 | 2016-12-07 | — | — | CN | claimed |
| CN-101497593-B | 5-hydroxy coumarin and pyranoid type coumarin compounds, synthesizing method and use | UNIV SOUTH CHINA TECH | 2011-09-21 | — | — | CN | claimed |
| CN-101497593-A | 5-hydroxy coumarin and pyranoid type coumarin compounds, synthesizing method and use | UNIV SOUTH CHINA TECH (CN) | 2009-08-05 | — | — | CN | claimed |
| CN-1225998-C | Cigarette additive extracted from natural plant, and extracting method and use in cigarette thereof | SHENNONG YANKE TECHNOLOGY CO L (CN) | 2005-11-09 | — | — | CN | claimed |
| CN-1488300-A | Cigarette additive extracted from natural plant, and extracting method and use in cigarette thereof | 广东神农烟科技术有限公司 | 2004-04-14 | — | — | CN | claimed |
| US-5608085-A | Synthesis of optically active calanolides A and B and enantiomers and related compounds | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) | 1997-03-04 | — | — | US | claimed |
| WO-1996026934-A1 | SYNTHESIS OF OPTICALLY ACTIVE CALANOLIDES A AND B AND ENANTIOMERS AND RELATED COMPOUNDS | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) | 1996-09-06 | — | — | WO | claimed |
| US-5432014-A | Flat display element | SANYO ELECTRIC CO., LTD. (JP) | 1995-07-11 | — | — | US | claimed |
| EP-4346772-B1 | PHOSPHOLIPID FORMULATIONS OF 1'-CYANO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS | GILEAD SCIENCES INC (US) | 2026-04-01 | — | — | EP | disclosed |
| EP-4714452-A1 | METHODS FOR TREATING SARS COV-2 INFECTIONS | Gilead Sciences, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| EP-4132651-B1 | INHALATION FORMULATIONS OF 1'-CYANO SUBSTITUTED CARBANUCLEOSIDE ANALOGS | GILEAD SCIENCES INC (US) | 2026-03-18 | — | — | EP | disclosed |
| US-3994828-A | Nonabsorbable antioxidant | DYNAPOL CORPORATION (US) | 1976-11-30 | — | — | US | disclosed |
| US-3973979-A | MAGENTA DYES, SILVER HALIDE EMULSIONS | AGFA-GEVAERT, A.G. (DT) | 1976-08-10 | — | — | US | disclosed |
| US-3965122-A | ANTIALLERGENS | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1976-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250064758-A1 | ANTIVIRALS TARGETING PHOSPHATIDIC ACID PHOSPHATASE (PAP) | ACE, ACE2, PPP3CA | CA12 2096/4885CA9 3077/4885CA1 4302/4885 |
| US-11660307-B2 | Methods for treating SARS CoV-2 infections | ACE2, ACE, PNP | CA12 770/4885CA9 1275/4885CA1 3405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.